BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17667947)

  • 1. Biodistribution and tumor infectivity of semliki forest virus vectors in mice: effects of re-administration.
    Rodriguez-Madoz JR; Prieto J; Smerdou C
    Mol Ther; 2007 Dec; 15(12):2164-71. PubMed ID: 17667947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Semliki forest virus vector engineered to express IFNα induces efficient elimination of established tumors.
    Quetglas JI; Fioravanti J; Ardaiz N; Medina-Echeverz J; Baraibar I; Prieto J; Smerdou C; Berraondo P
    Gene Ther; 2012 Mar; 19(3):271-8. PubMed ID: 21734727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon.
    Vasilevska J; Skrastina D; Spunde K; Garoff H; Kozlovska T; Zajakina A
    Cancer Gene Ther; 2012 Aug; 19(8):579-87. PubMed ID: 22722377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
    Rodriguez-Madoz JR; Prieto J; Smerdou C
    Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
    Määttä AM; Liimatainen T; Wahlfors T; Wirth T; Vähä-Koskela M; Jansson L; Valonen P; Häkkinen K; Rautsi O; Pellinen R; Mäkinen K; Hakumäki J; Hinkkanen A; Wahlfors J
    Int J Cancer; 2007 Aug; 121(4):863-70. PubMed ID: 17443493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography.
    Asselin-Paturel C; Lassau N; Guinebretière JM; Zhang J; Gay F; Bex F; Hallez S; Leclere J; Peronneau P; Mami-Chouaib F; Chouaib S
    Gene Ther; 1999 Apr; 6(4):606-15. PubMed ID: 10476220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.
    Klimp AH; van der Vaart E; Lansink PO; Withoff S; de Vries EG; Scherphof GL; Wilschut J; Daemen T
    Gene Ther; 2001 Feb; 8(4):300-7. PubMed ID: 11313804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.
    Kramer MG; Masner M; Casales E; Moreno M; Smerdou C; Chabalgoity JA
    BMC Cancer; 2015 Sep; 15():620. PubMed ID: 26347489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
    Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
    Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphavirus vectors for gene therapy applications.
    Lundstrom K
    Curr Gene Ther; 2001 May; 1(1):19-29. PubMed ID: 12109136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.
    Ballesteros-Briones MC; Martisova E; Casales E; Silva-Pilipich N; Buñuales M; Galindo J; Mancheño U; Gorraiz M; Lasarte JJ; Kochan G; Escors D; Sanchez-Paulete AR; Melero I; Prieto J; Hernandez-Alcoceba R; Hervas-Stubbs S; Smerdou C
    Mol Ther; 2019 Nov; 27(11):1892-1905. PubMed ID: 31563534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic nanoparticles for efficient cell transduction with Semliki Forest virus.
    Kurena B; Vežāne A; Skrastiņa D; Trofimova O; Zajakina A
    J Virol Methods; 2017 Jul; 245():28-34. PubMed ID: 28315379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
    Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
    J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade.
    Quetglas JI; Labiano S; Aznar MÁ; Bolaños E; Azpilikueta A; Rodriguez I; Casales E; Sánchez-Paulete AR; Segura V; Smerdou C; Melero I
    Cancer Immunol Res; 2015 May; 3(5):449-54. PubMed ID: 25691326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector.
    Murphy AM; Sheahan BJ; Atkins GJ
    Int J Cancer; 2001 Nov; 94(4):572-8. PubMed ID: 11745446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
    Del Vecchio C; Calistri A; Lombardi G; Celegato M; Biasolo MA; Palù G; Parolin C
    Gene Ther; 2009 Feb; 16(2):279-90. PubMed ID: 19037240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta.
    Roks AJ; Henning RH; Buikema H; Pinto YM; Kraak MJ; Tio RA; de Zeeuw D; Haisma HJ; Wilschut J; van Gilst WH
    Gene Ther; 2002 Jan; 9(2):95-101. PubMed ID: 11857067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semliki Forest virus vectors for gene therapy.
    Lundstrom K
    Expert Opin Biol Ther; 2003 Aug; 3(5):771-7. PubMed ID: 12880377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.